No abstract

No abstract

No abstract

Functionalization of biologically relevant molecules for the labeling with the novel fac-[(99m)Tc(OH(2))(3)(CO)(3)](+) precursor has gained considerable attention recently. Therefore, we tested seven different tridentate (histidine L(1)(), iminodiacetic acid L(2)(), N-2-picolylamineacetic acid L(3)(), N, N-2-picolylaminediacetic acid L(4)()) and bidentate (histamine L(5)(), 2-picolinic acid L(6)(), 2,4-dipicolinic acid L(7)()) ligand systems, with the potential to be bifunctionalized and attached to a biomolecule. The ligands allowed mild radiolabeling conditions with fac-[(99m)Tc(OH(2))(3)(CO)(3)](+) (30 min, 75 degrees C). The ligand concentrations necessary to obtain yields of >95% of the corresponding organometallic complexes 1-7 ranged from 10(-)(6) to 10(-)(4) M. Complexes of the general formula "fac-[(99m)TcL(CO)(3)]" (L = tridentate ligand) and "fac-[(99m)Tc(OH(2))L'(CO)(3)]" (L' = bidentate ligand), respectively, were produced. Challenge studies with cysteine and histidine revealed significant displacement of the ligands in complexes 5-7 but only little exchange with complexes 1-4 after 24 h at 37 degrees C in PBS buffer. However, no decomposition to (99m)TcO(4)(-) was observed under these conditions. All complexes showed a hydrophilic character (log P(o/w) values ranging from -2.12 to 0.32). Time-dependent FPLC analyses of compounds 1-7 incubated in human plasma at 37 degrees C showed again no decomposition to (99m)TcO(4)(-) after 24 h at 37 degrees C. However, the complexes with bidentate ligands (5-7) became almost completely protein bound after 60 min, whereas the complexes with tridentate coordinated ligands (1-4) showed no reaction with serum proteins. The compounds were tested for their in vivo stability and the biodistribution characteristics in BALB/c mice. The complexes with tridentate coordinated ligand systems (1-4) revealed generally a good and fast clearance from all organs and tissues. On the other hand, the complexes with only bidentate coordinated ligands (5-7) showed a significantly higher retention of activity in the liver, the kidneys, and the blood pool. Detailed radiometric analyses of murine plasma samples, 30 min p.i. of complex fac-[(99m)TcL(1)(CO)(3)], 1, revealed almost no reaction of the radioactive complex with the plasma proteins. By contrast, in plasma samples of mice, which were injected with complex fac-[(99m)Tc(OH(2))L(5)(CO)(3)](+), 5, the entire radioactivity coeluded with the proteins. On the basis of these in vitro and in vivo experiments, it appears that functionalization of biomolecules with tridentate-chelating ligand systems is preferable for the labeling with fac-[(99m)Tc(OH(2))(3)(CO)(3)](+), since this will presumably result in radioactive bioconjugates with better pharmacokinetic profiles.

No abstract

We have developed a technetium labeling technology based on a new organometallic chemistry, which involves simple mixing of the novel reagent, a 99m Tc(I)-carbonyl compound, with a His-tagged recombinant protein. This method obviates the labeling of unpaired engineered cysteines, which frequently create problems in large-scale expression and storage of disulfide-containing proteins. In this study, we labeled antibody single-chain Fv fragments to high specific activities (90 mCi/mg), and the label was very stable to serum and all other challenges tested. The pharmacokinetic characteristics were indistinguishable from iodinated scFv fragments, and thus scFV fragments labeled by the new method will be suitable for biodistribution studies. This novel labeling method should be applicable not only to diagnostic imaging with 99mTc, but also to radioimmunotherapy approaches with 186/188 Re, and its use can be easily extended to almost any recombinant protein or synthetic peptide.

Increased long-term performance was found for photocatalytic H(2) production in a homogeneous combination of [Re(NCS)(CO)(3)bipy] (1; bipy = 2,2'-bipyridine), [Co(dmgH)(2)] (dmgH(2) = dimethylglyoxime), triethanolamine (TEOA), and [HTEOA][BF(4)] in N,N-dimethylformamide, achieving TON(Re) up to 6000 (H/Re). The system proceeded by reductive quenching of *1 by TEOA, followed by fast (k(1) = 1.3 x 10(8) M(-1) s(-1)) electron transfer to [Co(II)(dmgH)(2)] and subsequent protonation (K(2)) and elimination (k(3), second-order process in cobalt) of H(2). Observed quantum yields were up to approximately 90% (H produced per absorbed photon). The type of acid had a substantial effect on the long-term stability. A decomposition pathway involving cobalt is limiting the long-term performance. Time-resolved infrared (IR) spectroscopy confirmed that photooxidized TEOA generates a second reducing equivalent, which can be transferred to 1 (70%, k(2e)(-) = 3.3 x 10(8) M(-1) s(-1)) if no [Co(II)(dmgH)(2)] is present.

Photocatalytic hydrogen production in pure water for three component systems using a series of rhenium-based photosensitizers (PS) and cobalt-based water reduction catalysts (WRC), with triethanolamine (TEOA) as an irreversible electron donor, is described. Besides the feasibility of this reaction in water, key findings are reductive quenching of the excited state of the PS by TEOA (k(q) = 5-8 × 10(7) M(-1) s(-1); Φ(cage) = 0.75) and subsequent transfer of an electron to the WRC (k(Co(III)) = 1.1 × 10(9) M(-1) s(-1)). Turnover numbers in rhenium (TON(Re), H/Re) above 500 were obtained, whereas TON(Co) (H(2)/Co) did not exceed 17. It is shown that the cobalt-based WRC limits long-term performance. Long-term performance critically depends on pH and the type of WRC used but is unaffected by the type of PS or the concentration of WRC. A quantum yield of 30% was obtained (H/photon).